Detailed answers about SHAOXING FUQING MEDICAL PRODUCTS CO., LTD., including incorporation, status, business activity, and accounts information.
When was SHAOXING FUQING MEDICAL PRODUCTS CO., LTD. founded?
SHAOXING FUQING MEDICAL PRODUCTS CO., LTD. was officially incorporated on 20 July 2021 and is registered under company number 13519974. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is SHAOXING FUQING MEDICAL PRODUCTS CO., LTD.?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of SHAOXING FUQING MEDICAL PRODUCTS CO., LTD.?
SHAOXING FUQING MEDICAL PRODUCTS CO., LTD.'s current status is Active - Proposal to Strike off. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does SHAOXING FUQING MEDICAL PRODUCTS CO., LTD. do?
SHAOXING FUQING MEDICAL PRODUCTS CO., LTD. operates in the following sector: 32500 - Manufacture of medical and dental instruments and supplies. This provides insight into the company's primary business activity and industry focus.
What is SHAOXING FUQING MEDICAL PRODUCTS CO., LTD.'s registered address?
The registered office address of SHAOXING FUQING MEDICAL PRODUCTS CO., LTD. is CHASE BUSINESS CENTRE, 39-41 CHASE SIDE, LONDON, ENGLAND, N14 5BP. This is the official address filed with Companies House for legal and statutory correspondence.
Is SHAOXING FUQING MEDICAL PRODUCTS CO., LTD. financially stable?
The most recent accounts for SHAOXING FUQING MEDICAL PRODUCTS CO., LTD. were made up to 31 July 2024, filed as DORMANT. Next accounts are due by 30 April 2026.